Inventor · disambiguated record
Bettina Strack-Logue
Also filed as: STRACK-LOGUE BETTINA
11 granted patents·11 pending applications·38 citations·filing 2005–2022
88Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES11TRANSLATE BIO INC3SHIRE NPS PHARMACEUTICALS INC2CHURCH GEORGE1CONCINO MICHAEL F1
Top patents by PatentIndex Score
22 records- 0195US10144942B2Modification of RNA-related enzymes for enhanced productionTRANSLATE BIO INC·Filed 2016·Granted Dec 4, 2018·10 cites·1 claims
- 0289US10995354B2Modification of RNA-related enzymes for enhanced productionTRANSLATE BIO INC·Filed 2018·Granted May 4, 2021·2 cites·3 claims
- 0389US9814764B2Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Nov 14, 2017·9 cites·20 claims
- 0486US10722559B2Mannose-6-phosphate bearing peptides fused to lysosomal enzymesSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Jul 28, 2020·5 cites·11 claims
- 0583US11660328B2GLP-2 analogs and peptibodies for administration before, during or after surgeryTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 30, 2023·2 cites·8 claims
- 0683US11065307B2Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moietySHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted Jul 20, 2021·2 cites·8 claims
- 0782US9932377B2Mitochondrial targeting and therapeutic use thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Apr 3, 2018·2 cites·4 claims
- 0880US10603364B2Lysosomal targeting and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 31, 2020·2 cites·7 claims
- 0975US9260495B2Mitochondrial targeting and therapeutic use thereofKEEFE DENNIS·Filed 2012·Granted Feb 16, 2016·4 cites·7 claims
- 1073US2022010347A1Modification of rna-related enzymes for enhanced productionTRANSLATE BIO INC·Filed 2021·Application pending·0 cites
- 1167US2023031280A1Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditionsSHIRE NPS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1256US2020376095A1Mannose-6-phosphate bearing peptides fused to lysosomal enzymesSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 1352US2022133863A1Treatment of sanfilippo syndrome type bSHIRE HUMAN GENETIC THERAPIES·Filed 2021·Application pending·0 cites
- 1452US2020199192A1Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditionsSUN KEFENG·Filed 2018·Application pending·0 cites
- 1545US2021355187A1Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditionsSHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1642US9597376B2Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 21, 2017·0 cites·14 claims
- 1739US2017202929A1Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 1838US2019085095A1Anti-c5 antibodies with enhanced ph switchSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 1935US2011318327A1Treatment of sanfilippo syndrome type bCONCINO MICHAEL F·Filed 2011·Application pending·0 cites
- 2034US2016130324A1C1 Inhibitor Fusion Proteins and Uses ThereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 2133US2007269870A1Methods for assembly of high fidelity synthetic polynucleotidesCHURCH GEORGE·Filed 2005·Application pending·0 cites
- 2229US9453847B2Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereofRUIZ JUAN·Filed 2011·Granted Sep 27, 2016·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Bettina Strack-Logue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →